Surrey researchers Sign in
Back
Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites
Journal article

Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites

VA Jennings, EJ Ilett, KJ Scott, EJ West, R Vile, H Pandha, K Harrington, A Young, GD Hall, M Coffey, …
INTERNATIONAL JOURNAL OF CANCER, Vol.134(5), pp.1091-1101
01/03/2014
DOI: https://doi.org/10.1002/ijc.28450

Abstract

Science & Technology Life Sciences & Biomedicine Oncology ONCOLOGY antitumor immunity malignant ascites neutralizing antibodies reovirus ANTITUMOR IMMUNITY T-CELLS ANTIVIRAL IMMUNITY IN-VITRO TUMOR VIRUS INFECTION COMBINATION MELANOMA INNATE
url
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000328246700008&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View
Author

Metrics

33 Record Views
35 Times Cited - Web of Science

Details

Usage Policy

Usage details for all content viewed and downloaded in this site are shared with IRUS-UK (Institutional Repository Usage Statistics UK). Cookies are used to remember your decision. Click Accept to accept usage details sharing and the cookies.

Learn more